SuperworthCardio Diagnostics shares outstanding CDIO
Diluted shares outstanding, averaged over each quarter, from 2022.
- Latest quarter, to Jun 30, 2026
- 3M
- On a year earlier
- +70.2%
- more shares
Cardio Diagnostics had 3M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 70.2% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 1.8M | +39% |
| FY2024 | 1.3M | +108% |
| FY2023 | 631.7K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 3M | +70% | |
| Q1 FY26 | 2.8M | +68% | |
| Q4 FY25 | 1.8M | +39% | |
| Q3 FY25 | 1.8M | +116% | |
| Q2 FY25 | 1.7M | +131% | |
| Q1 FY25 | 1.7M | +140% | |
| Q4 FY24 | 1.3M | +108% | |
| Q3 FY24 | 814.8K | +105% | |
| Q2 FY24 | 753.6K | +121% | |
| Q1 FY24 | 702.6K | +121% | |
| Q4 FY23 | 631.7K | n/a | |
| Q3 FY23 | 396.8K | +80% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Cardio Diagnostics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.